Oxford Biolabs' goal is to provide an ultimate cure for hair loss. The research is ongoing to continuously improve and update the current TRX2® formula as well as create supporting products to further improve the effectiveness of
“A” for Androgenetic Alopecia and Alert
Androgenetic alopecia is a common prevailing form of hair loss in men and women that causes an adverse impact on one's appearance and emotional state, causing a receding hairline and diffuse thinning across the scalp – a potential sign of stress. The inevitable result of this pattern of hair loss are the hereditary genetic conditions that may result in baldness if special attention is not paid at the onset of thinning. Dihydrotestosterone (DHT), a hormone responsible for shortening of the anagen phase of hair growth eventually leads to the shrinking of hair follicles and their excessive loss. Strong, thick hair is gradually replaced by thin, short shafts that have a tendency to fall out in the course of time. The disruption of the normal hair growth cycle is an alert worth taking notice of at the earliest stages.
TRX2® - natural molecular solution
TRX2® has been a leading research project exclusively devoted to providing a better option for those with androgenetic alopecia. By combining powerful metabolic stimulants (potassium chloride, BCAA, nicotinic acid) with a naturally-based, energy-generating substance (L-carnitine-L-tartrate),
TRX2® helps to nourish hair follicles
on a molecular level.
Since 2011, we have been manufacturing and distributing TRX2® throughout the world in the form of the TRX2® Molecular Food Supplement for Hair. In 2015, we developed two topical solutions using our unique formula, TRX2® Revitalising Hair Foam and TRX2® Revitalising Hair Lotion. Visit our TRX2® product website at
for more information.